Show pageBacklinksCite current pageExport to PDFBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. There is a grave need for the identification of [[molecular targets]] for therapeutic treatment and [[biomarker]]s as risk predictors for [[hemorrhagic stroke]] [[prevention]]. Based on reported various perturbed angiogenic signaling cascades mediated by the CCM signaling complex (CSC), there have been many proposed candidate drugs, targeting potentially angiogenic-relevant signaling pathways dysregulated by loss of function of one of the CCM proteins, which might not be enough to correct the pathological phenotype, hemorrhagic CCMs ((Zhang J, Abou-Fadel JS. Calm the raging hormone - A new therapeutic strategy involving progesterone-signaling for hemorrhagic CCMs. Vessel Plus. 2021;5:48. Epub 2021 Jul 5. PMID: 35098046; PMCID: PMC8796995.)) hemorrhagic_stroke_prevention.txt Last modified: 2024/06/07 02:49by 127.0.0.1